TABLE 1.
Baseline clinical data from patients measured before surgery
| Variable | Remission | Nonremission | p value | p value (adj) |
|---|---|---|---|---|
| No. of patients | 26 | 12 | ||
| Age at time of SG (y) | 45.5 (38.25;54) | 58 (56.25;65.25) | 0 | 0.004 |
| BMI before SG (kg/m2) | 46.87 (43.33;50.77) | 45.87 (43.65;52.75) | 0.975 | 0.975 |
| Percentage of body fat before SG (%) | 47.1 (44.77;50.58) | 49.4 (44.83;51.4) | 0.46 | 0.594 |
| Fasting blood insulin before SG (IU/mL) | 34.55 (29.53;53.57) | 34.72 (27.55;43.52) | 0.396 | 0.567 |
| Plasma insulin measured at 30 min during OGTT (n = 35; IU/ml) | 128.08 (109.6;173.73) | 74.08 (61.61;126.53) | 0.031 | 0.091 |
| Plasma insulin measured at 60 min during OGTT (n = 35; IU/mL) | 159.18 (146.12;231.63) | 123.27 (73.27;168.24) | 0.213 | 0.395 |
| Plasma insulin measured at 120 min during OGTT (n = 35; IU/mL) | 121.86 (82.54;243.84) | 90.56 (52.09;105.67) | 0.045 | 0.118 |
| Number of chronic diseases before SG (1 or more) | 19 (73%) | 12 (100%) | 0.084 | 0.546 |
| Number of chronic disease medications before SG (2 or more) | 12 (46%) | 12 (100%) | 0.017 | 0.216 |
| HbA1c before SG (%) | 6.4 (5.9;6.88) | 7.1 (6.65;8.25) | 0.005 | 0.021 |
| Fasting blood glucose before SG (mg/dL) | 132.5 (123.25;143.5) | 154.5 (146.75;178.75) | 0 | 0.004 |
| Plasma glucose measured at 30 min during OGTT (n = 35; mg/dL) | 232.5 (194.5;239) | 248 (235;271) | 0.011 | 0.042 |
| Plasma glucose measured at 60 min during OGTT (n = 35; mg/dL) | 248 (224.75;282.25) | 298 (283;315) | 0.002 | 0.012 |
| Plasma glucose measured at 120 min during OGTT (n = 35; mg/dL) | 194.5 (159.75;218.25) | 225 (183;243) | 0.186 | 0.395 |
| Bilirubin before SG (mg/dL) | 0.47 (0.36;0.59) | 0.38 (0.3;0.57) | 0.307 | 0.499 |
| C‐reactive protein before SG (mg/L) | 5.89 (2.62;10.53) | 3.92 (1.69;10.24) | 0.48 | 0.594 |
| Cholesterol before SG (mg/dL) | 190 (165.5;214) | 184 (152.5;203.25) | 0.387 | 0.567 |
| Triglyceride before SG (mg/dL) | 146 (131.25;231) | 163 (126;225) | 0.888 | 0.923 |
| High‐density lipoprotein before SG (mg/dL) | 39.5 (35;45) | 44.5 (37.75;53.5) | 0.209 | 0.395 |
| Low‐density lipoprotein before SG (mg/dL) | 118.5 (97.12;146) | 103.95 (82.83;133.75) | 0.272 | 0.471 |
| White blood cell count before SG (103/uL) | 7.95 (6.65;9.07) | 8.2 (7.5;8.62) | 0.753 | 0.879 |
| Red blood cell count before SG (106/uL) | 4.98 (4.7;5.26) | 5.07 (4.82;5.29) | 0.777 | 0.879 |
| Platelet blood count before SG (103/uL) | 224 (203.75;263) | 209.5 (190;283.75) | 0.414 | 0.567 |
| Hemoglobin cell count before SG (g/dL) | 14.35 (13.25;15.05) | 14.45 (13.3;15.05) | 0.826 | 0.895 |
| Male sex | 16 (61.5%) | 10 (83.3%) | 0.333 | 0.546 |
| Diabetes medication before SG (n = 37) | 3 (12%) | 10 (83.3%) | 0 | 0.003 |
Values show the median (first;third quartiles) or the number of patients and percentages. p values are shown for the χ2 test (categorical variables) and Kruskal‐Wallis test (continuous variables). Rows with p < 0.05 are shown in bold. Multiple testing correction was done using the false discovery method. If not otherwise stated, n = 38.
Abbreviations: adj, adjusted; OGTT, oral glucose tolerance test; sleeve gastrectomy.